Want to see AU:EBR full AI Analyst Report?
EBR Stock Chart & Stats
AU$1.32
-AU$0.01(-0.70%)
At close: 4:00 PM EST
AU$1.32
-AU$0.01(-0.70%)
Day’s Range― - ―
52-Week RangeAU$0.32 - AU$1.38
Previous CloseN/A
Volume292.81K
Average Volume (3M)694.25K
Market Cap
AU$210.70M
Enterprise ValueAU$172.55M
Total Cash (Recent Filing)AU$30.03M
Total Debt (Recent Filing)AU$59.85M
Price to Earnings (P/E)―
Beta1.35
Next Earnings
Aug 31, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding7,531,923,300
10 Day Avg. Volume604,410
30 Day Avg. Volume694,249
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)9.73
Price to Sales (P/S)148.94
P/FCF Ratio-4.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.19Price Target Upside66.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.09
Revenue Forecast (FY)AU$16.15M
Bulls Say, Bears Say
Bulls Say
Product / Business ModelEBR's core product is a leadless implantable pacing system with delivery tools and supporting tech. A focused, device-centric business model targets a structural need in cardiac rhythm management, creating durable IP and specialized commercialization pathways.
Early Commercialization TractionRecording revenue in 2025 with roughly 30% gross margin shows the product can generate sales and positive gross economics. This initial commercial proof reduces technical/market risk and supports a multi-month path to scale if distribution and adoption continue.
Balance Sheet BufferPositive equity and rising asset base provide a financial buffer against operational losses. While not sufficient alone, this capital and assets can underwrite near-term commercialization and provide collateral or capital-raising optionality over the coming months.
Bears Say
Heavy Cash BurnSustained negative operating and free cash flow signal large ongoing cash consumption. Continued burn requires external funding, creating durable execution risk if capital markets tighten or if commercial ramp delays extend beyond the company's runway.
Large Net Losses & Weak ProfitabilityA substantial net loss relative to tiny revenue demonstrates the business is far from profitability. Persistent negative operating leverage implies material structural improvements in revenue scale or cost structure are required to reach sustainable margins.
Rising LeverageIncreasing debt and a higher debt-to-equity ratio elevate financial risk and interest/service obligations. Higher leverage narrows strategic flexibility, may increase refinancing risk and could force dilutive or expensive financing if operating deficits persist.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh News
EBR FAQ
What was EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price range in the past 12 months?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh lowest share price was AU$0.32 and its highest was AU$1.38 in the past 12 months.
What is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap is AU$210.70M.
When is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date is Aug 31, 2026 which is in 39 days.
How were EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s earnings last quarter?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh released its earnings results on Mar 26, 2026. The company reported -AU$0.04 earnings per share for the quarter, missing the consensus estimate of AU$0 by -AU$0.04.
Is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh overvalued?
According to Wall Street analysts EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price is currently Undervalued.
Does EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh pay dividends?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh does not currently pay dividends.
What is EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate is -0.05.
How many shares outstanding does EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh have?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 7,531,923,300 shares outstanding.
What happened to EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price movement after its last earnings report?
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh reported an EPS of -AU$0.04 in its last earnings report, missing expectations of AU$0. Following the earnings report the stock price went down -1.48%.
Which hedge fund is a major shareholder of EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh?
Currently, no hedge funds are holding shares in AU:EBR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$2.19 (66.16% Upside)
AU$2.19 (66.16% Upside)
Blogger Sentiment
Bullish
AU:EBR Sentiment 97%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$219.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.25%
Trailing 12-Months
Company Description
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart. This innovative approach helps overcome the typical challenges linked to traditional pacing leads, including complex insertion, inadvertent nerve activation, displacement, removal procedures, and subsequent adjustments. Established in 2003, the company operates out of Sunnyvale, California.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR) Earnings & Revenues
EBR Stock 12 Month Forecast
Average Price Target
AU$2.19
▲(66.16% Upside)
Technical Analysis
Cochlear
―
Impedimed Limited
―
Uscom Limited
―
Micro-X Ltd.
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―







